• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国政府科技报告 >Diagnosis and Treatment of Coronary Heart Disease in Women: Systematic Reviews of Evidence on Selected Topics. Evidence Report/Technology Assessment Number 81
【24h】

Diagnosis and Treatment of Coronary Heart Disease in Women: Systematic Reviews of Evidence on Selected Topics. Evidence Report/Technology Assessment Number 81

机译：女性冠心病的诊断和治疗：选择主题证据的系统评价。证据报告/技术评估编号81

获取原文
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The Agency for Healthcare Research and Quality (AHRQ) and the National Institutes of Health Office of Research on Women's Health funded the University of California, San Francisco-Stanford Evidence-based Practice Center to perform systematic reviews and meta-analysis on four key topics related to coronary heart disease (CHD) in women: (1) accuracy of exercise myocardial perfusion imaging and echocardiography for diagnosis of CHD in women, (2) lipid lowering treatment to reduce risk of CHD in women, (3) diabetes as a risk factor for CHD in women, and (4) troponin as a prognostic factor for CHD in women. For each question, we also attempted to provide evidence stratified by race or ethnicity. We used standard methods to systematically review the medical literature to address each topic. The evidence identified was reviewed and graded, data were abstracted and the finders summarized for each topic. We developed specific search terms for each of the four key topics and performed standardized searches of electronic databases. We also reviewed bibliographies and sought suggestions from our peer reviewers. Authors of studies that met selection criteria but did not report findings by gender were contacted and asked to provide gender-specific outcomes.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号